Why Analysts Are Closely Watching Novartis AG (NVS) [Yahoo! Finance]
Novartis AG (NVS)
Last novartis ag earnings: 4/28 01:00 am
Check Earnings Report
US:NYSE Investor Relations:
novartis.com/investors
Company Research
Source: Yahoo! Finance
AG (NYSE:NVS) with a Buy rating and a price target of CHF 133, TheFly reported. According to the analyst, the company is well-positioned to sustain its strong momentum, with 5%-6% annual sales growth guidance through 2030. Earlier on January 20, Novartis AG (NYSE:NVS) said that it is likely to be protected from U.S. tariffs by mid-2026. As told by CEO Vas Narasimhan to CNBC, We expect to be in a position by middle of this year where we are not really exposed to tariffs, because we're able to produce in the U.S. for the U.S. We have inventory on hand. adriaticfoto/Shutterstock.com What reaffirms this optimistic view is the company's agreement with the U.S. government, which is expected to exclude Novartis AG (NYSE:NVS) from tariffs. These comments follow the Trump Administration's plans to impose 10% tariffs on many European countries, including the UK, Denmark, Sweden, and Germany. The company is also investing in regional supply chains to minimize its exposure to trade polici
Show less
Read more
Impact Snapshot
Event Time:
NVS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVS alerts
High impacting Novartis AG news events
Weekly update
A roundup of the hottest topics
NVS
News
- Even Near an All-Time High, This Dividend ETF Looks Extremely Cheap [Yahoo! Finance]Yahoo! Finance
- NFL Greats and Novartis Tackle Prostate Cancer Myths at Super Bowl LX: "Relax, It's a Blood Test"PR Newswire
- Breakthrough Therapy Status For Ianalumab Could Be A Game Changer For Novartis (SWX:NOVN) [Yahoo! Finance]Yahoo! Finance
- Eaton Vance Worldwide Health Sciences Fund Reduces Stake in Novo Nordisk AS by 49.25% [Yahoo! Finance]Yahoo! Finance
- Jim Cramer is Optimistic About Novartis' (NVS) Cancer Drug [Yahoo! Finance]Yahoo! Finance
NVS
Earnings
- 10/28/25 - Miss
NVS
Sec Filings
- 1/16/26 - Form S-8
- 1/16/26 - Form S-8
- 1/16/26 - Form S-8
- NVS's page on the SEC website